Study details
Enrolling now
Individualizing Treatment for Asthma in Primary Care (Full Study)
DARTNet Institute
NCT IDNCT07052942ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
3,200
Study length
about 4.3 years
Ages
13–75
Locations
13 sites in CO, FL, KS +7
About this study
Researchers are testing whether using inhaled corticosteroids (ICS) or azithromycin as a treatment to reduce asthma attacks in primary care patients. The trial will compare these two approaches individually and together.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Azithromycin
- 2.Take Inhaled corticosteroid (ICS)
- 3.Use Asthma Symptom Monitoring Web-based Application
PhasePhase 4
DrugAzithromycin
Routeinjection
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
azithromycin, corticosteroid
Drug routes
injection, intravenous, inhaled
Endpoints
Secondary: Asthma Quality of Life Questionnaire (AQLQ) as Measured by the Juniper Mini Asthma Quality of Life Questionnaire
Body systems
Respiratory